Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ozlem Silan Coskun

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Life Sciences|April 14, 2023
MALT1 paracaspase is overexpressed in hepatocellular carcinoma and promotes cancer cell survival and growthAsli Kurden-Pekmezci, Ece Cakiroglu, Sude Eris, et al.
Experimental and Molecular Pathology|November 12, 2018
Smooth muscle cell differentiation from rabbit amniotic cellsUfuk Senel, Ozlem Silan Coskun, Emre Can Tuysuz, et al.
Cell Death & Disease|April 24, 2026
Correction: Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancerBengisu Dayanc, Sude Eris, Nazife Ege Gulfirat, et al.
Cell Death & Disease|May 25, 2025
Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancerBengisu Dayanc, Sude Eris, Nazife Ege Gulfirat, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Life Sciences|April 14, 2023
MALT1 paracaspase is overexpressed in hepatocellular carcinoma and promotes cancer cell survival and growthAsli Kurden-Pekmezci, Ece Cakiroglu, Sude Eris, et al.
Experimental and Molecular Pathology|November 12, 2018
Smooth muscle cell differentiation from rabbit amniotic cellsUfuk Senel, Ozlem Silan Coskun, Emre Can Tuysuz, et al.
Cell Death & Disease|April 24, 2026
Correction: Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancerBengisu Dayanc, Sude Eris, Nazife Ege Gulfirat, et al.
Cell Death & Disease|May 25, 2025
Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancerBengisu Dayanc, Sude Eris, Nazife Ege Gulfirat, et al.
Pageof 1